Quanta Inc (fka QNTA)

[groverdongles]

Let’s look at a functional comparison to QNTA and Escozine.

BPSR has a drug, Zofin, already approved for FDA IND clinical trials for multiple conditions, and it only ran to around .60 in April. (Oddly just a day before QNTA’s run to .20….hmmmm). It is trading in the low teens right now.

BPSR has a much higher O/S count right now. But Zofin is approved to treat multiple conditions outside of COVID (COPD and others). I’m not sure if QNTA will hit dollars, but it won’t be because Escozine gets FDA IND approval. It will be because of the O/S structure. And if they add shares, it won’t go any higher than about .30-.40 on FDA news.

Granted, QNTA has other products and other revenue streams too. But just my opinion.